# Biotech Daily Digest ‚Äî 2025-11-18

**52 items from 4 sources**

## Summary by Source

- Endpoints News: 8 items
- Fierce Biotech: 5 items
- MHRA ‚Äì News: 1 item
- arXiv q-bio: 38 items


## Endpoints News

- **[Roche‚Äôs oral SERD delays early breast cancer recurrence in late-stage trial](https://endpoints.news/roches-oral-serd-delays-early-breast-cancer-recurrence-in-late-stage-trial/)**  
  _Tue, 18 Nov 2025 12:08:53 +0000_  
  Roche said Tuesday that its breast cancer pill beat standard of care when used after surgery. This could set the drug up as a new therapy of choice in this setting, the company added.  ...

- **[Lifordi gets new funding from Sanofi as it preps to test ADC in rheumatoid arthritis](https://endpoints.news/lifordi-gets-new-funding-from-sanofi-as-it-preps-to-test-adc-in-rheumatoid-arthritis/)**  
  _Tue, 18 Nov 2025 12:00:59 +0000_  
  For patients with chronic immune diseases, glucocorticoids are a double-edged sword. They can have potent effects quelling the disorders, but serious side effects with long-term use.

 Now, a small startup based just outside of Boston ...

- **[Vanda says its drug can halve vomiting risk in patients using GLP-1s](https://endpoints.news/vanda-says-its-drug-can-halve-vomiting-risk-in-patients-using-glp-1s/)**  
  _Tue, 18 Nov 2025 11:57:39 +0000_  
  Vanda Pharmaceuticals said a drug candidate that it licensed from Eli Lilly significantly reduced vomiting and nausea rates in a mid-stage trial of overweight and obese people taking a GLP-1 agonist.

 Around 29% of patients ...

- **[Drugmakers say HHS' 340B pilot is limited as they fight for their own rebate models](https://endpoints.news/drugmakers-say-hhs-340b-pilot-is-limited-as-they-fight-for-their-own-rebate-models/)**  
  _Mon, 17 Nov 2025 21:00:33 +0000_  
  Counsel for Eli Lilly, Novartis and Bristol Myers Squibb told a panel of judges that the government‚Äôs rebate pilot program is too limited in scope to address drugmakers‚Äô broader concerns with the 340B system.  ...

- **[Zymeworks and Jazz tout HER2 bispecific success in first Phase 3 readout](https://endpoints.news/zymeworks-and-jazz-tout-her2-bispecific-success-in-two-first-line-cancers/)**  
  _Mon, 17 Nov 2025 20:44:06 +0000_  
  Zymeworks and Jazz Pharmaceuticals said that the addition of their HER2 bispecific Ziihera helped stave off disease progression in certain patients with gastroesophageal adenocarcinoma ‚Äî a type of cancer that occurs in the stomach, esophagus and ...

- **[Novo Nordisk lowers self-pay prices for weight loss drugs ahead of Lilly, TrumpRx](https://endpoints.news/novo-nordisk-lowers-self-pay-prices-for-weight-loss-drugs-ahead-of-lilly-trumprx/)**  
  _Mon, 17 Nov 2025 18:22:42 +0000_  
  Novo Nordisk said Monday it will immediately drop its cash-pay prices for megablockbusters Ozempic and Wegovy to $349 per month, more than six weeks before Eli Lilly‚Äôs rival weight loss drug Zepbound is expected to ...

- **[How the Lilly-Adverum deal came together; Captain T Cell reels in ‚Ç¨20M](https://endpoints.news/how-the-lilly-adverum-deal-came-together-captain-t-cell-reels-in-e20m/)**  
  _Mon, 17 Nov 2025 16:10:06 +0000_  
  Plus, news about Starboard, Pfizer, Avadel Pharmaceuticals, Nxera Pharma, Siolta Therapeutics, Inventiva, Agomab, Charles River, Insilico Medicine, Genuine Biotech, CentryMed, Merus, Halozyme, MitoRx Therapeutics and Repare Therapeutics:

 ü§ù Adverum's partner hunt ended with a ...

- **[Merck is still hunting for deals after two major bolt-on acquisitions this year](https://endpoints.news/merck-is-still-hunting-for-deals-after-two-major-bolt-on-acquisitions-this-year/)**  
  _Mon, 17 Nov 2025 15:58:32 +0000_  
  It appears $19 billion in deals this year is just the beginning of Merck's plan to build its next chapter.

 Merck has the world's top-selling medicine, but it will need a suite of treatments to ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/roches-oral-serd-goes-2-2-hitting-goal-phase-3-adjuvant-breast-cancer-trial" hreflang="en">Roche‚Äôs oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial</a>](https://www.fiercebiotech.com/biotech/roches-oral-serd-goes-2-2-hitting-goal-phase-3-adjuvant-breast-cancer-trial)**  
  _Nov 18, 2025 8:39am_  
  Roche has reported another phase 3 win for its oral selective estrogen receptor degrader. Success at a planned interim analysis positions giredestrant for use in the adjuvant setting, setting the Swiss drugmaker up to target a currently unoccupied niche of a competitive market.

- **[<a href="https://www.fiercebiotech.com/biotech/genmab-sheds-another-clinical-adc-18b-profoundbio-buy" hreflang="en">Genmab sheds another clinical ADC from $1.8B ProfoundBio buy</a>](https://www.fiercebiotech.com/biotech/genmab-sheds-another-clinical-adc-18b-profoundbio-buy)**  
  _Nov 17, 2025 1:46pm_  
  Genmab has shed another antibody-drug conjugate from its April 2024 acquisition of ProfoundBio. The Danish pharma has dropped development of GEN1160, a company spokesperson confirmed to Fierce Biotech, halting a phase 1/2 trial of the asset.

- **[<a href="https://www.fiercebiotech.com/biotech/repare-finds-fix-biotech-agrees-xenotherapeutics-buyout" hreflang="en">Repare finds fix as biotech agrees to XenoTherapeutics buyout</a>](https://www.fiercebiotech.com/biotech/repare-finds-fix-biotech-agrees-xenotherapeutics-buyout)**  
  _Nov 17, 2025 12:10pm_  
  After laying off most of its staff and partnering away its phase 3 cancer asset earlier this year, precision oncology outfit Repare Therapeutics has agreed to be acquired by nonprofit biotech XenoTherapeutics.

- **[<a href="https://www.fiercebiotech.com/research/nih-grant-cuts-have-disrupted-hundreds-clinical-trials-study-finds" hreflang="en">NIH grant cuts have disrupted hundreds of clinical trials, study finds</a>](https://www.fiercebiotech.com/research/nih-grant-cuts-have-disrupted-hundreds-clinical-trials-study-finds)**  
  _Nov 14, 2025 3:39pm_  
  The second Trump administration has been defined by widespread cuts to federal spending, including at the National Institutes of Health (NIH). A new analysis reveals that the termination of NIH grants has disrupted at least 383 clinical trials, which collectively include more than 74,000 patients.

- **[<a href="https://www.fiercebiotech.com/biotech/jj-buys-halda-cell-death-tech-3b-acquisition-beefing-prostate-cancer" hreflang="en">J&amp;J buys into Halda's cell death tech with $3B acquisition, beefing up prostate cancer pipeline</a>](https://www.fiercebiotech.com/biotech/jj-buys-halda-cell-death-tech-3b-acquisition-beefing-prostate-cancer)**  
  _Nov 17, 2025 9:54am_  
  At the center of the acquisition is Halda‚Äôs ‚Äúhold and kill‚Äù bifunctional small molecule platform and a lead candidate in prostate cancer.


## MHRA ‚Äì News

- **[Decision: Orphan registered medicinal products](https://www.gov.uk/government/publications/orphan-registered-medicinal-products)**  
  _2025-11-18T14:06:12Z_  
  A list of authorised orphan medicinal products registered by the UK licensing authority.


## arXiv q-bio

- **[A Stochastic Quantum Neural Network Model for Ai](https://arxiv.org/abs/2511.11609)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.11609v1 Announce Type: new 
Abstract: Artificial intelligence (AI) has drawn significant inspiration from neuroscience to develop artificial neural network (ANN) models. However, these models remain constrained by the Von Neumann architecture and struggle to capture the complexity of the biological brain. Q‚Ä¶

- **[Protein Structure Tokenization via Geometric Byte Pair Encoding](https://arxiv.org/abs/2511.11758)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.11758v1 Announce Type: new 
Abstract: Protein structure is central to biological function, and enabling multimodal protein models requires joint reasoning over sequence, structure, and function. A key barrier is the lack of principled protein structure tokenizers (PSTs): existing approaches fix token size o‚Ä¶

- **[Understanding Molecular Basis of PTPN11-Related Diseases](https://arxiv.org/abs/2511.11860)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.11860v1 Announce Type: new 
Abstract: The PTPN11 gene encodes the Src homology 2 domain-containing protein tyrosine phosphatase (SHP2), a key regulator of cell growth, differentiation, and apoptosis through its modulation of various signaling pathways, including the RAS/MAPK signaling pathway. Missense vari‚Ä¶

- **[SarcGraph for High-Throughput Regional Analysis of Sarcomere Organization and Contractile Function in 2D Cardiac Muscle Bundles](https://arxiv.org/abs/2511.11913)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.11913v1 Announce Type: new 
Abstract: Timelapse images of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) provide rich information on cell structure and contractile function. However, it is challenging to reproducibly generate tissue samples and conduct scalable experiments with these‚Ä¶

- **[Comment on "Repair of DNA Double-Strand Breaks Leaves Heritable Impairment to Genome Function"](https://arxiv.org/abs/2511.11986)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.11986v1 Announce Type: new 
Abstract: Bantele and colleagues recently reported that repair of a single CRISPR/Cas9-induced DNA double-strand break (DSB) in the c-MYC topologically associated domain leads to a persistent depletion of chromatin interactions and long-term transcriptional attenuation across mul‚Ä¶

- **[Agent-Based Modelling in Cellular Biology - Are we flexible yet?](https://arxiv.org/abs/2511.12161)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.12161v1 Announce Type: new 
Abstract: Cellular Agent-Based Models are commonly employed to describe a variety biological systems. Over the course of the past years, many modeling tools have emerged which solve particular research questions. In this short opinion piece, we argue that existing frameworks lack‚Ä¶

- **[AMR-MoEGA: Antimicrobial Resistance Prediction using Mixture of Experts and Genetic Algorithms](https://arxiv.org/abs/2511.12223)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.12223v1 Announce Type: new 
Abstract: Antimicrobial resistance (AMR) poses a mounting global health crisis, requiring rapid and reliable prediction frameworks that capture its complex evolutionary dynamics. Traditional antimicrobial susceptibility testing (AST), while accurate, remains laborious and time-co‚Ä¶

- **[Explainable deep learning framework for cancer therapeutic target prioritization leveraging PPI centrality and node embeddings](https://arxiv.org/abs/2511.12463)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.12463v1 Announce Type: new 
Abstract: We developed an explainable deep learning framework integrating protein-protein interaction (PPI) network centrality metrics with node embeddings for cancer therapeutic target prioritization. A high-confidence PPI network was constructed from STRING database interaction‚Ä¶

- **[A mark and recapture perspective on vaccination touchpoints](https://arxiv.org/abs/2511.12536)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.12536v1 Announce Type: new 
Abstract: This paper considers large-scale vaccination campaigns, a major platform for vaccine access in a lot of the world, as a recapture estimate of the target population marked by routine immunization. Framing the campaign as a measurement, we learn about its properties, incl‚Ä¶

- **[Predicting upcoming visual features during eye movements yields scene representations aligned with human visual cortex](https://arxiv.org/abs/2511.12715)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.12715v1 Announce Type: new 
Abstract: Scenes are complex, yet structured collections of parts, including objects and surfaces, that exhibit spatial and semantic relations to one another. An effective visual system therefore needs unified scene representations that relate scene parts to their location and th‚Ä¶

- **[Treatment of phenol wastewater by electro-Fenton oxidative degradation based on efficient iron-based-gas diffusion-photocatalysis](https://arxiv.org/abs/2511.12843)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.12843v1 Announce Type: new 
Abstract: This study introduces a novel iron-based gas diffusion electrode-photocatalytic system aimed at enhancing the degradation of phenolic compounds in wastewater. Phenolic compounds are toxic environmental pollutants with significant resistance to biodegradation. The tradit‚Ä¶

- **[Brain Networks Flow-Topology via Variance Minimization in the Wasserstein Space](https://arxiv.org/abs/2511.12990)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.12990v1 Announce Type: new 
Abstract: This work introduces a novel framework for testing topological variability in weighted networks by combining Hodge decomposition with Wasserstein variance minimization. Traditional approaches that analyze raw edge weights are susceptible to noise driven perturbations, l‚Ä¶

- **[Bridging the genotype-phenotype gap with generative artificial intelligence](https://arxiv.org/abs/2511.13141)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13141v1 Announce Type: new 
Abstract: The genotype-phenotype gap is a persistent barrier to complex trait genetic dissection, worsened by the explosive growth of genomic data (1.5 billion variants identified in the UK Biobank WGS study) alongside persistently scarce and subjective human-defined phenotypes.‚Ä¶

- **[Causal Inference, Biomarker Discovery, Graph Neural Network, Feature Selection](https://arxiv.org/abs/2511.13295)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13295v1 Announce Type: new 
Abstract: Biomarker discovery from high-throughput transcriptomic data is crucial for advancing precision medicine. However, existing methods often neglect gene-gene regulatory relationships and lack stability across datasets, leading to conflation of spurious correlations with g‚Ä¶

- **[Modeling Spatial Synchronization of Predator-Prey Oscillations via the XY Model under Demographic Stochasticity and Migration](https://arxiv.org/abs/2511.13501)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13501v1 Announce Type: new 
Abstract: We investigate stochastic predator-prey dynamics and their spatial phase synchronization using the Rosenzweig-MacArthur model coupled across multiple patches. Combining stochastic simulations based on the Gillespie algorithm with analytical methods inspired by the XY mo‚Ä¶

- **[MDIntrinsicDimension: Dimensionality-Based Analysis of Collective Motions in Macromolecules from Molecular Dynamics Trajectories](https://arxiv.org/abs/2511.13550)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13550v1 Announce Type: new 
Abstract: Molecular dynamics (MD) simulations provide atomistic insights into the structure, dynamics, and function of biomolecules by generating time-resolved, high-dimensional trajectories. Analyzing such data benefits from estimating the minimal number of variables required to‚Ä¶

- **[Evaluating and Scoring Ebolavirus Protein-protein Docking Models Using PIsToN](https://arxiv.org/abs/2511.13583)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13583v1 Announce Type: new 
Abstract: Protein-protein docking is crucial for understanding how proteins interact. Numerous docking tools have been developed to discover possible conformations of two interacting proteins. However, the reliability and success of these docking tools rely on their scoring funct‚Ä¶

- **[Integrative Model for Interoception and Exteroception: predictive coding, points of modulation, and testable predictions](https://arxiv.org/abs/2511.13668)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13668v1 Announce Type: new 
Abstract: Interoception and exteroception provide continuous feedback about the body and the environment, yet how they are dynamically integrated within a unified predictive coding framework has remained under-specified. This paper develops and empirically validates an integrativ‚Ä¶

- **[Multiscale Grassmann Manifolds for Single-Cell Data Analysis](https://arxiv.org/abs/2511.11717)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.11717v1 Announce Type: cross 
Abstract: Single-cell data analysis seeks to characterize cellular heterogeneity based on high-dimensional gene expression profiles. Conventional approaches represent each cell as a vector in Euclidean space, which limits their ability to capture intrinsic correlations and mult‚Ä¶

- **[Socrates-Mol: Self-Oriented Cognitive Reasoning through Autonomous Trial-and-Error with Empirical-Bayesian Screening for Molecules](https://arxiv.org/abs/2511.11769)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.11769v1 Announce Type: cross 
Abstract: Molecular property prediction is fundamental to chemical engineering applications such as solvent screening. We present Socrates-Mol, a framework that transforms language models into empirical Bayesian reasoners through context engineering, addressing cold start probl‚Ä¶

- **[The Probabilistic Foundations of Surveillance Failure: From False Alerts to Structural Bias](https://arxiv.org/abs/2511.12459)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.12459v1 Announce Type: cross 
Abstract: For decades, forensic statisticians have debated whether searching large DNA databases undermines the evidential value of a match. Modern surveillance faces an exponentially harder problem: screening populations across thousands of attributes using threshold rules rat‚Ä¶

- **[Genomic Next-Token Predictors are In-Context Learners](https://arxiv.org/abs/2511.12797)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.12797v1 Announce Type: cross 
Abstract: In-context learning (ICL) -- the capacity of a model to infer and apply abstract patterns from examples provided within its input -- has been extensively studied in large language models trained for next-token prediction on human text. In fact, prior work often attrib‚Ä¶

- **[cryoSENSE: Compressive Sensing Enables High-throughput Microscopy with Sparse and Generative Priors on the Protein Cryo-EM Image Manifold](https://arxiv.org/abs/2511.12931)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.12931v1 Announce Type: cross 
Abstract: Cryo-electron microscopy (cryo-EM) enables the atomic-resolution visualization of biomolecules; however, modern direct detectors generate data volumes that far exceed the available storage and transfer bandwidth, thereby constraining practical throughput. We introduce‚Ä¶

- **[Departures: Distributional Transport for Single-Cell Perturbation Prediction with Neural Schr\"odinger Bridges](https://arxiv.org/abs/2511.13124)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13124v1 Announce Type: cross 
Abstract: Predicting single-cell perturbation outcomes directly advances gene function analysis and facilitates drug candidate selection, making it a key driver of both basic and translational biomedical research. However, a major bottleneck in this task is the unpaired nature‚Ä¶

- **[BIOMERO 2.0: end-to-end FAIR infrastructure for bioimaging data import, analysis, and provenance](https://arxiv.org/abs/2511.13611)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13611v1 Announce Type: cross 
Abstract: We present BIOMERO 2.0, a major evolution of the BIOMERO framework that transforms OMERO into a FAIR-compliant (findable, accessible, interoperable, and reusable), provenance-aware bioimaging platform. BIOMERO 2.0 integrates data import, preprocessing, analysis, and w‚Ä¶

- **[Rare Genomic Subtype Discovery from RNA-seq via Autoencoder Embeddings and Stability-Aware Clustering](https://arxiv.org/abs/2511.13705)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13705v1 Announce Type: cross 
Abstract: Unsupervised learning on high-dimensional RNA-seq data can reveal molecular subtypes beyond standard labels. We combine an autoencoder-based representation with clustering and stability analysis to search for rare but reproducible genomic subtypes. On the UCI "Gene Ex‚Ä¶

- **[Modeling Dynamic Neural Activity by combining Naturalistic Video Stimuli and Stimulus-independent Latent Factors](https://arxiv.org/abs/2410.16136)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2410.16136v3 Announce Type: replace 
Abstract: The neural activity in the visual processing is influenced by both external stimuli and internal brain states. Ideally, a neural predictive model should account for both of them. Currently, there are no dynamic encoding models that explicitly model a latent state an‚Ä¶

- **[Unlocking tropical forest complexity: How tree assemblages in secondary forests boost biodiversity conservation](https://arxiv.org/abs/2503.02523)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2503.02523v2 Announce Type: replace 
Abstract: Secondary forests now dominate tropical landscapes and play a crucial role in achieving COP15 conservation objectives. This study develops a replicable national approach to identifying and characterising forest ecosystems, with a focus on the role of secondary fores‚Ä¶

- **[Bizard: A Community-Driven Platform for Accelerating and Enhancing Biomedical Data Visualization](https://arxiv.org/abs/2503.06845)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2503.06845v2 Announce Type: replace 
Abstract: Biomedical research increasingly relies on heterogeneous, high-dimensional datasets, yet effective visualization remains hindered by fragmented code resources, steep programming barriers, and limited domain-specific guidance. Bizard is an open-source visualization c‚Ä¶

- **[Combining multiplexed functional data to improve variant classification](https://arxiv.org/abs/2503.18810)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2503.18810v2 Announce Type: replace 
Abstract: With the surge in the number of variants of uncertain significance (VUS) reported in ClinVar in recent years, there is an imperative to resolve VUS at scale. Multiplexed assays of variant effect (MAVEs), which allow the functional consequence of 100s to 1000s of gen‚Ä¶

- **[Bifunctional enzyme action as a source of robustness in biochemical reaction networks: a novel hypergraph approach](https://arxiv.org/abs/2504.21011)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2504.21011v2 Announce Type: replace 
Abstract: Substrate modification networks are ubiquitous in living, biochemical systems. A higher-level hypergraph "skeleton" captures key information about which substrates are transformed in the presence of modification-specific enzymes. Many different detailed models can b‚Ä¶

- **[Fractal Geometry and Fractional Calculus for Integrative Morphological Mapping of Breast Cancer Complexity](https://arxiv.org/abs/2505.07338)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2505.07338v2 Announce Type: replace 
Abstract: Breast cancer exhibits intricate morphological and dynamical heterogeneity across cellular, tissue, and tumor scales, posing challenges to conventional modeling approaches that fail to capture its nonlinear, self-similar, or self-affine, and memory-dependent behavio‚Ä¶

- **[Threshold behavior of a social norm in response to error proneness](https://arxiv.org/abs/2506.23907)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2506.23907v2 Announce Type: replace 
Abstract: A social norm defines what is good and what is bad in social contexts, as well as what to do based on such assessments. A stable social norm should be maintained against errors committed by its players. In addition, individuals may have different probabilities of er‚Ä¶

- **[Finding low-complexity DNA sequences with longdust](https://arxiv.org/abs/2509.07357)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2509.07357v2 Announce Type: replace 
Abstract: Motivation: Low-complexity (LC) DNA sequences are compositionally repetitive sequences that are often associated with spurious homologous matches and variant calling artifacts. While algorithms for identifying LC sequences exist, they either do not define complexity‚Ä¶

- **[Graph Neural Network-Based Reinforcement Learning for Controlling Biological Networks - the GATTACA Framework](https://arxiv.org/abs/2505.02712)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2505.02712v3 Announce Type: replace-cross 
Abstract: Cellular reprogramming, the artificial transformation of one cell type into another, has been attracting increasing research attention due to its therapeutic potential for complex diseases. However, identifying effective reprogramming strategies through classi‚Ä¶

- **[Meta-Learning an In-Context Transformer Model of Human Higher Visual Cortex](https://arxiv.org/abs/2505.15813)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2505.15813v2 Announce Type: replace-cross 
Abstract: Understanding functional representations within higher visual cortex is a fundamental question in computational neuroscience. While artificial neural networks pretrained on large-scale datasets exhibit striking representational alignment with human neural resp‚Ä¶

- **[Associative Memory and Generative Diffusion in the Zero-noise Limit](https://arxiv.org/abs/2506.05178)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2506.05178v2 Announce Type: replace-cross 
Abstract: This paper shows that generative diffusion processes converge to associative memory systems at vanishing noise levels and characterizes the stability, robustness, memorization, and generation dynamics of both model classes. Morse-Smale dynamical systems are sh‚Ä¶

- **[A nonparametric approach to practical identifiability of nonlinear mixed effects models](https://arxiv.org/abs/2507.20288)**  
  _Tue, 18 Nov 2025 00:00:00 -0500_  
  arXiv:2507.20288v2 Announce Type: replace-cross 
Abstract: Mathematical modelling is a widely used approach to understand and interpret clinical trial data. This modelling typically involves fitting mechanistic mathematical models to data from individual trial participants. Despite the widespread adoption of this indi‚Ä¶
